ArticleEMBO molecular medicine2013

Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.

Anouk Emadali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.